ME agenda

Myalgic Encephalomyelitis | political issues | information | commentary | for the UK ME patient community

Archive for the ‘ME events’ Category

Participant List: MRC CFS/ME Research Workshop

Posted by meagenda on November 23, 2009

Received, today, from MRC Corporate Information and Policy under FOI:

Shortlink: http://wp.me/p5foE-2q2

PDF: participant list November 2009 (2)

23 November 2009

Please find attached a copy of the participants list for the workshop, as promised. This is also available on the MRC website at:

http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006510

Yours sincerely

Rosa Parker

Rosa Parker | Corporate Information and Policy

Medical Research Council

20 Park Crescent

London

W1B 1AL

———————

Ed: Please note that this list has been amended since this posting was first published as it contained transcription errors. If you have reposted the earlier version of this list, elsewhere, please replace with this  corrected version.

MRC CFS/ME Research Workshop

19th and 20th November 2009

Participant list

Dr Neil Abbot – ME Research UK

Professor Jangu Banatvala – King’s College London

Dr Kate Bishop – National Institute for Medical Research

Dr Gijs Bleijenberg – Radbound University

Professor Tim Cawston – University of Newcastle

Professor Trudie Chalder – King’s College London

Dr Charlotte Clark – Barts and the London

Professor Philip Cowen – University of Oxford

Dr Esther Crawley – University of Bristol

Professor Maria Fitzgerald – University College London

Dr Suzanne Hagan – Glasgow Caledonian University

Dr Kirstie Haywood – University of Warwick

Professor Stephen Holgate – University of Southampton

Professor Jim Horne – University of Loughborough

Dr Jonathan Kerr – St George’s University of London

Professor Paul Little – University of Southampton

Dr Samuele Marcora – Bangor University

Professor Chris Mathias – Imperial College London

Professor Paul Moss – University of Birmingham

Professor Rona Moss-Morris – University of Southampton

Dr Luis Nacul – London School of Hygiene and Tropical Medicine

Professor Julia Newton – University of Newcastle

Dr Derek Pheby – ME Observatory

Professor Anthony Pinching – Peninsula Medical School

Professor Chris Ponting - MRC Functional Genomics Unit

Professor Alan Rickinson – University of Birmingham

Dr Charles Shepherd – ME Association

Dr Vance Spence – ME Research UK

Sir Peter Spencer – Action for ME

Dr Jonathan Stoye – National Institute for Medical Research

Professor Chris Ward – University of Nottingham

Professor Peter White – Barts and the London

Mary-Jane Willow  – Association of Young People with ME

MRC Head office Staff

Dr Rob Buckle
Dr Jo Latimer

http://www.mrc.ac.uk/Ourresearch/ResearchFocus/CFSME/index.htm

MRC CFS/ME Research Workshop

The MRC held a small research workshop for CFS/ME on the 19 and 20th November 2009. The agenda, papers and meeting participants can be found at the links below

Agenda: MRC CFS/ME Research Workshop
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006511

List of participants of the MRC CFS/ME Research Workshop
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006510

[Open PDF at top of post]

[PDF Format]   Open here: CFSME Literature Review Jan 2004 – Jun 2009[1]   [3MB]

Papers circulated prior to the meeting:

CFS/ME Literature review Jan 2004 – June 2009
http://www.mrc.ac.uk/Utilities/Documentrecord/index.htm?d=MRC006509

Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome: Lombardi VC et al. Science. 2009 326:585-9

Note of the Workshop to follow

—————

[Ed: Note this is an unofficial note of the procedings prepared by Dr Charles Shepherd MEA, not the official MRC note of the Workshop.]

MRC Expert Group on ME/CFS: Brief Notes on Research Workshop held on 19/20 November 2009

Monday, 23 November 2009 16:42

The Medical Research Council’s Expert Group Workshop on ME/CFS Research took place on Thursday 19 November and Friday 20 November at Heythrop Park, Oxford. Around 30 researchers and clinicians from various disciplines, plus MRC staff, took part.

Besides those with existing expertise in this area, there were others present who were new to the subject and consequently brought fresh thinking to the issues and questions being discussed.

PRESENTATION SUMMARIES AND SLIDES

The MRC will be publishing summaries and slides from all the main presentations that were given – once this information has been checked and approved by those who gave the presentations.

I understand that the MRC will also be publishing a full list of everyone who attended this meeting.

The MEA website will carry a suitable link in our news box when all this information appears on the MRC website.

PRESENTATIONS

There were presentations followed by discussions on the following key topics on the first day:

Epidemiology and clinical phenotyping – Dr Esther Crawley
Autonomic dysfunction – Professor Julia Newton
Sleep – Professor Jim Horne
Pain – Professor Maria Fitzgerald
Neuropsychology – Professor Gijs Bleijenberg
Neuroimaging – Professor Phil Cowen
New technologies – Professor Chris Ponting
Immune system dysregulation and infection – Professor Tony Pinching
Virology – Professor Paul Moss

Although not covered by specific presentations, a number of other topics – including muscle abnormalities, mitochondrial dysfunction, post-mortem and tissue bank research – were referred to, along with the way in which patients under the ME/CFS umbrella should be defined and selected to take part in research studies.

The second day consisted of group discussions which considered the following topics:

capitalising on current issues and UK strengths in the area of ME/CFS research
the use of new technologies
partnership models
research prioritisation
Each group then reported back to facilitate a whole group discussion.

The meeting closed with a summing up and an explanation of the next steps forward from Professor Stephen Holgate, Chair of the MRC Expert Group.

BACKGROUND INFORMATION

Background information provided by the MRC included a 351-page literature review of the current state of ME/CFS research and paper copies of the XMRV paper from Science.

The MEA provided copies of the latest edition (October 2009) of our guidelines – ME/CFS/PVFS – An Exploration of the Key Clinical Issues -on research, clinical assessment and management.

INFECTION AND XMRV:

There was a great deal of lively discussion relating to all aspects of XMRV infection – ie existing research findings; replication of the preliminary results from research groups both here and abroad; implications for blood donation; possible pathogenicity of the XMRV infection; future research priorities – during the formal sessions, over dinner, and well into the night on Thursday. We were fortunate in having four researchers present who are all involved with taking this research forward and are well aware of what is happening both here and abroad.

It was made clear to all the researchers present who are involved in retroviral work that the MEA Ramsay Research Fund has money available if this is required urgently to help fund any immediate or short term funding requirement. The MEA is also very willing to look at more major grant proposals relating to XMRV.A link to the latest MEA summary on XMRV can be found on the home page of the MEA website and we will be updating this information later in the week. The website also has details of our exchange of correspondence with Sir Liam Donaldson, Chief Medical Officer, on the subject of blood donation.

The All Party Parliamentary Group on ME has XMRV on the agenda when it meets at the House of Commons on Wednesday 2 December. The Rt Hon Mike O’Brien, Minister of State (Health Services) at the Department of Health, will be present to deal with the main item on the agenda: the APPG Inquiry into NHS Services for people with ME/CFS. This meeting is open to the public – more details re time and venue can be found on the MEA website. If you are intending to come to the meeting please check the MEA website the day before because the House of Commons venue can change at short notice. And do allow at least 30 minutes from arriving at the House of Commons to get through security and find directions the right room.

The Countess of Mar’s Forward ME Group also has research on the agenda when they meet on Tuesday 24 November at the House of Lords.

The MRC workshop also discussed other infections, in particular herpes virus infections, that have been implicated in ME/CFS.

AUTONOMIC DYSFUNCTION: PROFESSOR JULIA NEWTON

Professor Julia Newton and her team at the University of Newcastle, who are working on autonomic dysfunction in ME/CFS, have just had a new paper published in the European Journal of Clinical Investigation. The paper describes an interesting practical approach to the management of symptoms relating to orthostatic intolerance. Ref: Sutcliffe K et al. Home orthostatic training in chronic fatigue syndrome – a randomised placebo-controlled feasibility study. EJCI, November 12 2009. If we can obtain an abstract of this EJCI paper it will be placed on the MEA website news box. The MEA Ramsay Research Fund is currently funding another study at the University of Newcastle to examine muscle energy metabolism in ME/CFS patients. More information can be found in the research section of the MEA website.

MRC: NEXT STEP FORWARD

There are a number of ways in which the MRC can help with a research agenda, in addition to providing finance for good new research proposals. So the next step forward in relation to ME/CFS will be for the MRC Expert Group to meet early in 2010 to discuss the content of this research workshop, along with the conclusions and recommendations that were produced during further discussion on defining research strengths and priorities on the second day.

Personal note

On a personal note I would like to add that while I have been extremely critical of the MRC in the past I believe that Professor Stephen Holgate, who is leading this ME/CFS initiative, is genuinely determined to take forward the biomedical research that the patient population, along with many doctors and researchers, believes is so vital if we are going to find effective forms of management for ME/CFS.

Membership of MRC Expert Group on ME/CFS Research

Professor Stephen Holgate (Chairman)
Professor Jill Belch
Professor Philip Cowen
Dr Esther Crawley
Professor Malcolm Jackson
Dr Jonathan Kerr
Professor Ian Kimber
Professor Hugh Perry
Dr Derek Pheby
Professor Anthony Pinching
Dr Charles Shepherd
Sir Peter Spencer
Dr Rob Buckle (MRC)
Dr Joanna Latimer (MRC)
Dr Charles Shepherd
Hon Medical Adviser, ME Association

23 November 2009

Posted in AfME, Action for M.E., CFS Research, Freedom of Information, ME Association, ME Research, ME events, MRC, Prof Holgate, Professor Peter White, XAND, XMRV, XMRV Retrovirus | Comments Off

MRC Research Workshop: Final Agenda

Posted by meagenda on November 19, 2009

MRC Research Workshop: Final Agenda

Shortlink: http://wp.me/p5foE-2pu

As I was in contact with MRC Corporate Information and Policy, today, I requested confirmation of the presenter on “Fatigue” at today’s meeting which had been listed on the Agenda as “tbc”.

I have been advised that it was not possible to secure a speaker for the proposed session on Fatigue, but that an Open Session was added towards the end of the day. 

A final copy of the Agenda was provided for my information. I am advised that this will be published on the MRC website, early next week.

Note that this is the 3rd Agenda that has been issued (on 19 November) and it supercedes the two previous files posted on this site and elsewhere.

Final Agenda provided on 19 November in PDF format: Final Agenda MRC CFS ME Workshop 19- 20 November 2009

Posted in AfME, Action for M.E., CFS Research, Freedom of Information, ME Association, ME Research, ME events, ME in children, MRC, Prof Holgate, Professor Peter White, XMRV, XMRV Retrovirus | Comments Off

APPG on ME: Agenda meeting 2 December 2009

Posted by meagenda on November 19, 2009

APPG on ME: Agenda meeting 2 December 2009

Shortlink: http://wp.me/p5foE-2pq

 

The APPG on ME maintains a website here: http://www.appgme.org.uk

Agenda APPG for ME 2 Dec 2009

APPG agenda 02/12/2009

19 December 2009

The next meeting of the All Party Parliamentary Group (APPG) on M.E. will be held 3.15-4.45pm, Wednesday 2 December 2009 in Committee Room 15, House of Commons.

1. Welcome by the Chairman

2. APPG Report on the Inquiry into NHS Services

3. Speaker: Mike O’Brien MP, Minister of State for Health Services

4. Minutes of the last meeting

5. Matters arising

- APPG legacy paper (in preparation for the General Election)

- New research: murine leukaemia virus-related virus (XMRV)

- Accessibility of venues for future meetings

6. Welfare update

- Employment and Support Allowance

- Welfare Reform Bill

7. Any other business

8. Date of next meeting

Posted in APPG on ME, APPG on ME Agenda, AfME, Action for M.E., Benefits, CFS Clinics, CFS Clinics Inquiry, CFS Research, Care, DWP, DoH, ME Association, ME Research, ME events, ME in Parliament, NHS, NHS service provision inquiry, Welfare reform, XMRV, XMRV Retrovirus | Comments Off

XMRV Retrovirus: Round up 23: WPI NYT article, Coffin on NPR Radio, papers

Posted by meagenda on November 14, 2009

XMRV Retrovirus: Round up 23: WPI NYT article, Coffin on NPR Radio, papers and Hillary Johnson on CFSAC

WordPress Shortlink: http://wp.me/p5foE-2nY

 

Media

New York Times  |  Denise Grady  |  11 November 2009

http://www.nytimes.com/2009/11/12/giving/12SICK.html

A Big Splash From an Upstart Medical Center

[A version of this article appeared in print on November 12, 2009, on page F8 of the New York edition.]

Related article: Is a Virus the Cause of Fatigue Syndrome? (October 13, 2009)

TO many people who suffer from the poorly understood illness called chronic fatigue syndrome, a recent study linking the disorder to a virus was a victory for the little guys.

For one thing, the study pointed to a physical cause for an illness that the medical establishment had often snidely dismissed as psychosomatic. The research could not be ignored: it was published last month in Science, one of the world’s pickiest and most prestigious journals…

Read full article here

—————-

NPR Radio  |  16 October 2009

Interview with Dr John Coffin (c0-author of Science Perspectives article)

http://www.npr.org/templates/story/story.php?storyId=113870280

10 mins 30 secs

Virus Tied To Chronic Fatigue Syndrome

Scientists have identified a virus lurking in 68 of 101 patients diagnosed with chronic fatigue syndrome. Whether the virus — known as XMRV — causes the syndrome is unclear. Molecular biologist John Coffin describes how the findings fit with what scientists know about XMRV.

Transcript also available

Scroll down NPR page for

Virus Linked To Chronic Fatigue Syndrome
by Jon Hamilton

8 October 2009

—————-

Papers

AHC Media LLC

http://ahcpub.com/hot_topics/?htid=1&httid=2005

Chronic Fatigue Syndrome — Could a “Stealth Virus” Be Lurking?

From Infectious Disease Alert | November 2009

Abstract & Commentary

By John F. Joseph, MD, FACP, FIDSA, FSHEA, Associate Chief of Staff for Education, Ralph H. Johnson Veterans Administration Medical Center; Professor of Medicine, Medical University of South Carolina, Charleston, is Associate Editor for Infectious Disease Alert.

Dr. John is a consultant for Cubist, Genzyme, and bioMerieux, and is on the speaker’s bureau for Cubist, GSK, Merck, Bayer, and Wyeth.

Source: Lombardi VC et al. Science. 8 October 2009 (10.1126/science.1179052).

Full Abstract and Commentary here

—————-

http://www.ncbi.nlm.nih.gov/pubmed/19906923?dopt=Abstract

J Virol. 2009 Nov 11. [Epub ahead of print]
Androgen Stimulates Transcription and Replication of XMRV (Xenotropic Murine Leukemia Virus-Related Virus).

Dong B, Silverman RH.

Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195.

XMRV is a gammaretrovirus originally identified in a subset of prostate cancer patients. Because androgens stimulate prostate tumors and some retroviruses, we investigated effects of dihydrotestosterone (DHT) on XMRV transcription and replication. Transcription from the XMRV U3 region was stimulated up to 2-fold by DHT, but only in cells containing a functional androgen receptor. Mutations in the glucocorticoid response element (GRE) of XMRV impaired basal transcription and androgen responsiveness. Furthermore, DHT stimulated XMRV replication by 3-fold, whereas androgen inhibitors (casodex and flutamide) suppressed viral growth up to 3-fold. Findings suggest that integration of the XMRV LTR into host DNA could impart androgen stimulation on cellular genes.

PMID: 19906923 [PubMed - as supplied by publisher]

—————-

Press Releases

Hemispherx

Source: Globe Newswire
Date: 11 November 2009
http://www.reuters.com/article/pressRelease/idUS198174+11-Nov-2009+GNW20091111 

Law offices Bernard M. Gross, P.C. filed a class action lawsuit against Hemispherx Biopharma, Inc.

Source: Marketwire
Date: 12 November 2009
http://finance.yahoo.com/news/INVESTOR-ALERT-Former-iw-3847944880.html

Investor Alert: Former Attorney General of Louisiana Charles C. Foti, Jr. and KSF notify Hemispherx Biopharma, Inc. investors of Lead Plaintiff Application Deadline in Securities Class Action Lawsuit

Source: MarketWire
Date: 12 November 2009
http://finance.yahoo.com/news/CORRECTION-Holzer-Holzer-iw-766428846.html 

Holzer Holzer & Fistel, LLC announces that it has filed a class action lawsuit on behalf of investors in Hemispherx Biopharma, Inc.

Source: MarketWire
Date:  12 November 2009
http://finance.yahoo.com/news/Izard-Nobel-LLP-Announces-iw-68919281.html

Izard Nobel LLP announces class action lawsuit against Hemispherx Biopharma, Inc.

—————-

Bloggers

Hillary Johnson  |  13 November 2009

New blog post about the recent CFSAC meeting in Washington, D.C. and the new scientific terrain created by the discovery of XMRV

THE FOG OF WAR

http://www.oslersweb.com/blog.htm?post=646449 

—————-

Commentary and quality forums

Rich Van Konynenburg via Co-Cure
12 November 2009

XMRV: necessary but not sufficient?

http://listserv.nodak.edu/cgi-bin/wa.exe?A2=ind0911b&L=co-cure&T=0&F=&S=&P=2951

—————-

Cort Johnson’s Phoenix Rising website: http://aboutmecfs.org/Rsrcs/XMRVResources.aspx

Cort Johnson’s Blog and comments: http://aboutmecfs.org/blog/

Cort Johnson’s Forums: http://forums.aboutmecfs.org/

Link Back

Whittemore Peterson Institute on Facebook

For initial Whittemore Peterson Press Release, NIH (National Institutes of Health) News Release, go here: http://wp.me/p5foE-272

For Science paper go here: http://wp.me/p5foE-2is

Click here for all previous XMRV Round ups and postings in reverse date order: http://meagenda.wordpress.com/category/xmrv/

Posted in Blood Donation, CFS Research, CFS in the media, CFSAC, Consultations, ME Research, ME events, ME in children, ME in journals, ME in the media, XAND, XMRV, XMRV Retrovirus | Comments Off

APPG on ME: Next meeting 2 December 2009 progress report

Posted by meagenda on November 13, 2009

1] APPG on ME: Next meeting 2 December 2009 progress report;

2] Agenda for next meeting of Countess of Mar’s caucus group Forward-ME;

3] Clarification regarding membership of the APPG on ME

Shortlink: http://wp.me/p5foE-2n3

Yesterday, 12 November, I contacted Action for M.E.’s Policy Officer for an ETA for the Minutes and transcript of the last meeting of the APPG on ME (21 October). I also enquired when the Agenda for the 2nd December meeting was anticipated to be issued.

Tristana Rodriguez, Action for M.E.’s Policy Officer, has advised that the transcript typist for the last APPG meeting had said that a full transcript could be expected within four weeks or so. A transcript has yet to be provided and this would be chased up by Ms Rodriguez, next week, as the transcript typist was currently away.

I was advised that since the Minutes would be produced using the transcript for reference, no timeframe could be given for the publication of the Minutes until the transcript has been provided to the secretariat.

As far as the Agenda for the meeting on 2 December goes, secretariat were in the process of finalising details with the invited speaker.  When this had been achieved, an Agenda would be circulated. When the Minutes and Agenda have been issued I will publish copies, here.

Before the October meeting, a group of members from the ME community met up for coffee.  If you are interested in attending the December meeting and would like to meet up with a few others before the meeting starts drop me an email via the Contact Form with “December APPG meeting” at the top and I can put you in touch.

Link Back

MEA summary of meeting of APPG on ME (21 October 2009) and APPG Legacy paper

Foward-ME

Forward-ME is a caucus group to the APPG on ME, convened and chaired by the Countess of Mar. Lady Mar decided which patient organisations would be extended an invitation to participate in her group and which would not. Unlike the APPG on ME, Forward-ME meets behind closed doors and members of the public are not able to attend, even as observers. Lady Mar convened this caucus group out of a desire to find “common ground” amongst the main patient organisations and the group appears to have superseded the now dormant ME Alliance.

No-one consulted with Lady Mar’s constituency of interest – the ME community – over whether a group which meets between meetings of the APPG, behind closed doors, would be welcomed and if so, what the extent of its remit should be, on what basis it would be decided to whom membership would be offered and how the wider ME community would inform its agenda. Forward-ME includes the organisation “ReMEmber” which promotes publications by Professor Michael Sharpe on its website; members also include representatives from Action for M.E., the MEA, AYME, the Young ME Sufferers Trust, Invest in ME, BRAME  and ME Research UK.

The 25% ME Group had been members but has since withdrawn support for Forward-ME. Invest in ME has already published its concerns in a statement (below) and its continued membership of the group is tabled for discussion at the next meeting of Forward-ME. 

Status 23rd March 2009

http://www.investinme.org/Article-182%20CoM%20Cooperation%20Meeting%2001.htm

 

A website for Forward-ME is maintained here where Minutes of previous meetings can be read and I append a copy of the Agenda for the next meeting:

http://www.forward-me.org.uk/24th%20November%202009.htm

FORWARD-ME

AGENDA FOR MEETING TO BE HELD

ON TUESDAY 24 NOVEMBER 2009

IN THE TELEVISION INTERVIEW ROOM, HOUSE OF LORDS

FROM 1.30 PM TO 3.00 PM.

1. Apologies.

2. Dr James Bolton, Deputy Chief Medical Adviser to the DWP.

3. Question and answer session.

4. Minutes of the meeting held on 8 July 2009.

5. Matters arising.

          i) Lightning Process

          ii) APPG Inquiry

          iii) MRC Project

          iv) Invest in ME membership of Forward-ME

6. Welfare Reform Bill.

7. Current Research.

8. Correspondence.

9. Any Other Business.

10. Date of next meeting.

Minutes of previous APPG on ME Meetings

The APPG on ME website now has PDF copies of Minutes of APPG meetings going back to 31 January 2001 collated at:  http://www.appgme.org.uk/minutes/mintues.html

Clarification regarding membership of the APPG on ME

There have been misunderstandings on some forums that AfME (Action for M.E.), the MEA (The ME Association), AYME (Association of Young People with ME), TYMES Trust (The Young ME Sufferers Trust), The 25% ME Group, ME Research UK, BRAME (Blue Ribbon for Awareness of ME) and RiME (Campaigning for Research into ME) are all members of the All-Party Parliamentary Group on ME.

None of the above are members of the APPG on ME.

In the case of Associate Parliamentary groups, applications for membership may be accepted by the group’s officers from organisations, interest groups, commercial concerns and individuals other than MPs or Members of the House of Lords.

But the All-Party Parliamentary Group on ME is not constituted as an Associate Parliamentary Group and therefore only Members of the House of Commons or the House of Lords are permitted membership of the APPG on ME, and only Members of the House of Commons or Lords have voting rights at its meetings.

So the only members of the APPG on ME are parliamentarians.

From the office of the Parliamentary Commissioner:

“Groups are only required to register with us the names of their officers and of 20 ‘qualifying members’. The full membership list, including names over and above that, resides with the group and it is for them to ensure that it is comprehensive and up to date. [...] Any MP (ie not just signed up members of the group) is entitled to turn up at any meeting of the group, and to speak and vote at the meeting – unless a subscription is charged in which case voting may be restricted to paid-up members of the group.”

The APPG on ME group’s current office holders and the twenty qualifying members (made up of cross party MPs and members of the House of Lords) can be viewed at the link, below.

http://www.publications.parliament.uk/pa/cm/cmallparty/register/memi389.htm

Under “BENEFITS RECEIVED BY GROUP FROM SOURCES OUTSIDE PARLIAMENT” AfME and The ME Association are listed as jointly providing the secretariat to the Group.

“Action for ME and The ME Association both provides secretarial support (addressing and stuffing envelopes, taking minutes, photocopying).”

AfME and the MEA have alternated the task of minute taking and circulation of minutes and agendas for these meetings but they are not members of the APPG Group and their status as organisations and that of their representatives in relation to the Group is no different to that of any other organisation that sends a representative to attend these meetings.

Although APPG groups are not permitted to advertise their meetings as “Public Meetings”, meetings of the APPG on ME are held in House of Commons committee rooms and are open to members of the public, that is, national ME patient organisations, representatives of the committees of “local” and regional ME support groups and other interested parties; they are also open to individual members of the ME community and their carers, who can and do regularly attend and contribute to these meetings.

So none of the five national registered membership ME patient organisations listed above are members of the APPG on ME but they attend APPG meetings, send their representives to meetings, and in the case of AfME and the MEA, provide the secretariat function.

ME Research UK : a research organisation and a registered charity (Scotland), represented at APPG on ME meetings by Mrs Sue Waddle, a former trustee of Invest in ME.

BRAME : unregistered, non membership, run by Christine Harrison and her daughter, Tanya. Both Christine and Tanya attend APPG on ME meetings.

RiME : unregistered, non membership, run by Paul Davies. Paul Davies attends APPG on ME meetings, sometimes supported by other individuals.

A number of ME sufferers and carers of ME sufferers attend APPG on ME meetings and their names are sometimes listed as attendees in the minutes of meetings; their contributions to these meetings are minuted.

I hope this clarifies any misconceptions about policy and proceedings at these meetings and the status of the organisations and individuals who attend them.

A Guide to the Rules on All Party Groups can be downloaded here:

http://www.parliament.uk/documents/upload/PCFSGroupsRules.pdf

Posted in APPG on ME, APPG on ME Agenda, APPG on ME Minutes, AfME, Action for M.E., CFS Clinics Inquiry, Countess of Mar, ME Association, ME events, ME in Parliament, NHS service provision inquiry | Comments Off

Text of Agenda for November MRC CFS/ME Workshop and AfME response

Posted by meagenda on November 12, 2009

Text of Agenda for MRC CFS/ME Expert Group Research Workshop 19-20 November 2009 and Action for M.E.’s Facebook response

Shortlink: http://wp.me/p5foE-2mD

Below is the text of the Agenda for the November MRC Workshop.  I have posted links for this Agenda and other information provided by the MRC, yesterday, on the Facebook Walls of Action for M.E. and the ME Association.  At the time of writing, neither organisation has published a copy of the Agenda, itself, on its main website.

Since flagging up the Agenda on Action for M.E.’s Facebook site, and some ensuing comments by users of the site, the following has been added by the moderators:

http://www.facebook.com/actionforme

“Sir Peter has asked Professor Holgate to ensure during the course of the two-day event that particular consideration be given to the XMRV findings and current efforts to replicate them by other researchers.”

“Action for M.E. MRC CFS/ME research workshop Sir Peter Spencer, CEO, Action for M.E. and other M.E. charity representatives will attend a multi-disciplinary workshop for researchers, organised by the Medical Research Council (MRC), 19-20 November.”

“The meeting, chaired by Professor Stephen Holgate, MRC Professor of Immunopharmacology from Southampton University, aims to encourage new research into M.E./CFS, harnessing the latest technologies and scientific thinking to develop a proper understanding of the underlying disease mechanisms.

Papers circulated include information about XMRV, the retrovirus identified in 68 out of 101 CFS patients by researchers at the Whittemore Peterson Institute in Reno, USA. Although the sample is small, the results have led to calls for greater investigation into the biology of M.E.

Sir Peter has asked Professor Holgate to ensure during the course of the two-day event that particular consideration be given to these findings and current efforts to replicate them by other researchers.

Anyone who wishes to contact Sir Peter about the workshop may do so by e-mailing consultations@afme.org.uk

“Scientists participating in the MRC workshop are already due to hear short presentations on phenotyping and epidemiology, autonomic dysfunction, fatigue, sleep, pain, neuroimaging, new technologies, immune dysregulation, infection and virology.

There will be an opportunity for group discussion before delegates split up into workshops.

These will consider:
- capitalising on current issues and UK scientific strengths
- new technologies and technological platforms
- national resources eg. patient cohorts
- partnership models
- research prioritisation
- other issues.

Professor Holgate will then summarise the workshop’s discussions, which will indicate a way forward for future work.”

 

Text of Agenda for MRC CFS/ME Research Workshop 19-20 November 2009

Note: I am advised by Ms Parker, MRC Corporate Governance and Policy, that “We are still in discussion with colleagues regarding the participants list and will respond to this part of your request in due course.”  I will post the list of participants when the MRC has fulfilled this part of the FOI request for information.

Also note that the timings, as set out in the document for the afternoon session of Day One, are squiffy. I have reproduced as supplied by the MRC in the PDF.

AGENDA in PDF format here: http://wp.me/p5foE-2mj

——————————

[MRC Logo] Medical Research Council

MRC CFS/ME Research Workshop

To be held on Thursday 19th & Friday 20th November

Location: Hethrop Park Resort (Chipping Norton, Oxfordshire OX7 5UF)

Agenda – Thursday 19th November

13:00 Registration; Lunch
Tea & Coffee
____________________________________________

13:30 Welcome and Introduction by Professor Stephen Holgate

Aims of the Workshop
____________________________________________

Short Presentations:

Topic    Speaker

13:45 CFS/ME phenotyping & epidemiology    Dr Esther Crawley

14:00 Autonomic dysfunction Professor    Julia Newton

14:45 Fatigue    tbc

14:15 Sleep Professor    Jim Horne

14:30 Pain Professor    Maria Fitzgerald

____________________________________________

15:00 Tea & Coffee
____________________________________________

15:30 Neuropsychology    Professor Gijs Bleijenberg

15:45 Neuroimaging    Professor Phil Cowen*

[*Ed: Philip Cowen is Professor of Psychopharmacology and MRC Clinical Scientist at the University of Oxford. His research and clinical interests are in the biochemistry and treatment of mood disorders, and particularly the pharmacological management of resistant depression.]

16:00 New Technologies    Professor Chris Ponting

16:15 Immune dysregulation/Infection    Professor Tony Pinching

16:00 Virology    Professor Paul Moss

____________________________________________

16:45 Tea & Coffee
____________________________________________

17:00-18:00 Group discussion
____________________________________________

19:00 Dinner
____________________________________________

Agenda – Friday 20th November

09:00 Introduction – brief for morning session – Professor Stephen Holgate

09:15 Working group discussions

‘What would you like to see the field respond to?’

Areas for consideration:
. capitalising on current issues and UK scientific strengths
. new technologies and technological platforms
. national resources e.g. patient cohorts
. partnership models
. other issues

______________________________________

10:45 Tea & Coffee
____________________________________________

11:00 Whole group discussion

11:45 Summing up and next steps – Professor Stephen Holgate

12:00 Close
____________________________________________

AGENDA in PDF format here: http://wp.me/p5foE-2mj

Link Back

Agenda: MRC CFS/ME Research Workshop 19-20 November 2009 and additional information provided by the MRC under FOIA:

WordPress Shortlink: http://wp.me/p5foE-2mj

The Agenda and Minutes of the meeting on 15 December can be downloaded here or opened in PDF format here:

PDF: Minutes CFS/ME Expert Group Meeting 15 December 2008

The list of members can be opened in PDF format here:

PDF: CFS/ME Expert group membership

Term of Reference can be opened in PDF format here:

PDF: Finalised Terms of Reference for CFS/ME expert group

or go to MRC site for full article and files:

Chronic Fatigue Syndrome/Myalgic Encephalomyelitis 

( http://www.mrc.ac.uk/Ourresearch/ResearchFocus/CFSME/index.htm )

Posted in AfME, Action for M.E., CFS Research, CFS in the media, Canadian Criteria, ME Association, ME Research, ME events, ME in journals, MRC, Prof Holgate, Professor Peter White, XMRV, XMRV Retrovirus | Comments Off

Top scientists to meet at Cleveland Clinic on trail of XMRV

Posted by meagenda on November 10, 2009

75 top scientists are flying in to convene on Wednesday at the Cleveland Clinic.

Top scientists to meet at Cleveland Clinic on trail of XMRV, a suspect in prostate cancer

WordPress Shortlink: http://wp.me/p5foE-2m6

http://www.cleveland.com/healthfit/index.ssf/2009/11/top_scientists_to_meet_at_clev.html

By Angela Townsend, The Plain Dealer
November 10, 2009, 6:00AM

Dr. Robert Silverman is a cancer biologist at the Cleveland Clinic instrumental in the discovery of the XMRV virus. Medical reporter Angela Townsend discusses this story at 7:35 this morning with WCPN FM/90.3’s Eric Wellman on Tuesday Check-up. Listen in or log in online. The virus XMRV has become a favorite topic in the scientific community — three years after its initial discovery in prostate cancer tumors by researchers from the Cleveland Clinic and the University of California, San Francisco…

[...]

Capitalizing on the excitement and heightened spirit of collaboration, 75 of the top scientists nationwide studying XMRV are flying in to convene Wednesday at the Clinic.

“This is the first meeting of the major players in the area of XMRV,” said John Coffin of the department of microbiology at Tufts University in Boston. “I think there’s going to be a lot of excitement and a lot of new information presented.”

Contact Angela Townsend: atownsen@plaind.com  or 216-999-3894.

Read full article here

 

Link back

For initial Whittemore Peterson Press Release and NIH (National Institutes of Health) News Release go here: http://wp.me/p5foE-272

For Science paper go here: http://wp.me/p5foE-2is

Go here for all previous XMRV Round ups and postings in reverse date order: http://meagenda.wordpress.com/category/xmrv/

Posted in CFS Research, CFS in the media, Canadian Criteria, ME Research, ME events, ME in journals, ME in the media, XAND, XMRV, XMRV Retrovirus | Comments Off

XMRV Retrovirus presentations: Klimas, de Meirleir, Hyde

Posted by meagenda on November 10, 2009

XMRV Retrovirus presentations: Klimas, de Meirleir, Hyde

WordPress Shortlink: http://wp.me/p5foE-2lh

Dr Nancy Klimas lecture, Florida, 7 November 2009

A video of Dr Nancy Klimas’s 7 November lecture is expected soon on Dan Moricoli’s CFS-ME Network, here:

http://cfsknowledgecenter.ning.com/

An earlier video, “Dr Nancy Klimas discusses the XMRV virus discovery, what it means, what’s next and what you can do”, recorded 12 October, can be viewed in the Video Section here:

http://cfsknowledgecenter.ning.com/video/klimas-on-xmrv

————–

Göteborg Conference, Sweden

Dr Byron Hyde: Missed Diagnoses
Dr Kenny de Meirleir: End of an Era of Medical Negation

Göteborg 10th November: Professional’s Day
Göteborg 11th November: Public meeting http://www.rme.nu/node/85

Malmö 12th November: Public Meeting http://www.skane.se/templates/Page.aspx?id=266536

According to Whittemore-Peterson Institute on Facebook, the Byron Hyde and Kenny de Meirleir lectures in Göteborg on Professionals Day, 10 November will be videotaped and placed on the internet.  A DVD will also be available for purchase at Riksföreningen ME Göteborg (email: goteborg@rme.nu).

http://www.rme.nu/lokala-foreningar/rme-goteborg

A PDF of Dr Hyde’s conference address is available here:

http://www.nightingale.ca/documents/GoteborgConference.pdf 

(Pages 7 and 8 for section: “The Whittemore Peterson Institute CFS – Retrovirus Announcement” )

Göteborg and Malmo, Sweden
M.E. Conferences: November 2009

Link back

For initial Whittemore Peterson Press Release and NIH (National Institutes of Health) News Release go here: http://wp.me/p5foE-272

For Science paper go here: http://wp.me/p5foE-2is

Go here for all previous XMRV Round ups and postings in reverse date order: http://meagenda.wordpress.com/category/xmrv/

Posted in CFS Research, CFS in the media, Canadian Criteria, ME Research, ME events, ME in children, ME in journals, ME in the media, ME in videos, XAND, XMRV, XMRV Retrovirus | Comments Off

XMRV Retrovirus Round up 22: WPI Press Release, ESME, 74 CFSAC meeting videos

Posted by meagenda on November 5, 2009

XMRV Retrovirus   Whittemore Peterson   Institute Science   Mikovits   Peterson   Chronic Fatigue Syndrome

XMRV Retrovirus: Round up 22: WPI Press Release, ESME, 74 CFSAC meeting videos

WordPress Shortlink: http://wp.me/p5foE-2jN

Press Releases

PDF here: WPI Release Diagnostic Test

http://www.wpinstitute.org/WPI%20Release%20Diagnostic%20Test.pdf

FOR IMMEDIATE RELEASE

Frankie Vigil
R&R Partners
775-336-4555
frankie.vigil@rrpartners.com

Viral Immune Pathology Diagnostics Introduces New Test for XMRV Patients and Clinicians
-Net proceeds from test dedicated to further WPI research-

RENO, Nev. – The Whittemore Peterson Institute (WPI) has recently published a research study revealing the prevalence of XMRV in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, ME/CFS or what has most recently been called, X associated neuro-immune disease, (XAND). In response to an overwhelming request for a diagnostic test for XMRV, WPI has temporarily agreed to allow Viral Immune Pathology Diagnostics (VIP Dx) to begin offering the identical tests that have been extensively validated using the same technology developed by Drs. Lombardi and Mikovits and their colleagues as reported in Science.

VIP Dx is a small state certified laboratory in Reno, Nevada that was formed in response to the September 11, 2001 crisis which resulted in the cessation of blood sample shipments between the United States and Europe. Faced with the loss of important lab tests impacting patients with neuro-immune diseases, the Whittemore family made the decision to support the lab in Reno.

“Our family made it possible for the lab to not only continue delivering diagnostic tests to doctors, but also help the WPI bring cutting edge biomarkers of disease to this field of medicine, such as the tests for XMRV,” said Annette  Whittemore, Founder and President of WPI. “Tests conducted for XMRV, and other tests that support the diagnostic process in this field, will support the continuation of vital work at WPI through our donation of all of our net proceeds.”

XMRV test acceptance commenced at VIP Dx this month.

For more information about the XMRV test kit, visit www.vipdx.com

Whittemore Peterson Institute  http://www.wpinstitute.org/

The Whittemore Peterson Institute for Neuro-Immune Disease exists to bring discovery, knowledge, and effective treatments to patients with illnesses caused by acquired dysregulation of the immune system and the nervous system, often resulting in lifelong disease and disability. The WPI is the first institute in the world dedicated to neuro immune diseases, integrating patient treatment, basic and clinical research and medical education.

—————-

CFSAC Two Day meeting: NIH videocasts now available plus 74 Video segments

http://cfsknowledgecenter.ning.com/video

74 videos covering the CFSAC Two Day meeting (29 – 30 October) on Dan Moricoli’s Ning ME-CFS Community.

—————-

NIH will be counting viewing figures to assess interest in making videocasts for these meetings available worldwide – so please view the videocasts on the NIH site:

Videocasts of CFSAC meeting 29-30 October 2008

Around 12 hours of video of the two day CFSAC meeting is now available at:

http://videocast.nih.gov/PastEvents.asp

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 1
Thursday, October 29, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 06:43:49

http://videocast.nih.gov/PastEvents.asp

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 2
Friday, October 30, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 05:15:09

Presentation

Dr David Bell’s PowerPoint slides: http://www.hhs.gov/advcomcfs/meetings/agendas/bell_factitious_102909.ppt

———-

Media

The Street   |  3 November 2009

http://www.thestreet.com/_yahoo/story/10620979/1/hemispherx-cops-to-ampligen-fda-delay.html

Ref: Hemispherx press release:

http://finance.yahoo.com/news/Hemispherx-Biopharma-Updates-pz-1535703186.html 

See also:

http://philadelphia.bizjournals.com/philadelphia/stories/2009/11/02/daily2.html

Hemispherx cops to Ampligen FDA delay

PHILADELPHIA, Pa. (TheStreet) – Hemispherx Biopharma(HEB Quote) issued an “update” to the regulatory status of its chronic fatigue syndrome drug Ampligen in which the company essentially admits that its prior public statements were false and misleading.

Monday’s statement was likely crafted by Hemispherx’s lawyers as a way to help CEO Bill Carter wiggle out of public statements he made in May and June claiming the Ampligen application to the U.S. Food and Drug Administration to be complete. Carter insisted regulators weren’t asking for any additional information on Ampligen.

Read full article here

—————-

Patient organisation statements

ESME www.esme-eu.com

Dear Whittemore Peterson Institute,

The Scientific Panel, the Board of Directors and the staff of ESME wish to congratulate the Whittemore Peterson Institute on the groundbreaking work they are performing in the area of neuro-immune diseases and especially their work with the XMRV virus. We applaud the thoroughness of your research and the openness with which you are sharing this research information with the world. We believe that by sharing scientific knowledge with this openness, you are starting a new era of scientific cooperation.

ESME would like to help the Whittemore Peterson Institute with information flow in Europe. We have the capacity to professionally translate information to Danish, Dutch, German, Norwegian, French and Spanish and we have a professional website where information can be posted in any of these languages: www.esme-eu.com  

ESME has also established a database of approximately 3000 e-mail addresses of European scientists, doctors, medical associations, national and regional ME associations, politicians, journalists and other people interested in ME/CFS. This database allows us to easily distribute information to professionals in many fields. We will gladly use our resources to assist the Whittemore Peterson Institute with the distribution of information in Europe.

In 2009, ESME held two conferences in Norway to educate healthcare personal (and patients) about the diagnostics, treatment, causes and consequences of ME/CFS. ESME will continue organizing these conferences in the coming years throughout Europe. We would like to invite a representative of the WPI to be a guest speaker at future European conferences to help us inform and train European MD’s and therapists better.

With Kind Regards,

ESME

—————-

Commentary

Cort Johnson’s Phoenix Rising website: http://aboutmecfs.org/Rsrcs/XMRVResources.aspx

Cort Johnson’s Blog and comments: http://aboutmecfs.org/blog/

Cort Johnson’s Forums: http://forums.aboutmecfs.org/

—————-

About.com  Fibromyalgia  and CFS Blog  | 5 November 2009

XMRV & Updated Mechanism Theory of Chronic Fatigue Syndrome

The XMRV Discovery Series

Dr. Daniel Peterson, one of the researchers involved in the possibly groundbreaking XMRV findings, testified before the NIH’s Chronic Fatigue Syndrome Advisory Committee Oct. 29. Among the many things he presented was an updated theory of how chronic fatigue syndrome (CFS or ME/CFS) develops. (Thanks to Dr. David S. Bell and his newsletter, Lyndonville News for putting this into language that was easier to understand!)

Read full article here

—————-

For initial Whittemore Peterson Press Release, NIH (National Institutes of Health) News Release, go here: http://wp.me/p5foE-272

For Science paper go here: http://wp.me/p5foE-2is

Click here for all previous XMRV Round ups and postings in reverse date order: http://meagenda.wordpress.com/category/xmrv/

The Definition Petition

Petition webpage: http://CFSdefinitionpetition.notlong.com
i.e. http://www.ipetitions.com/petition/empirical_defn_and_CFS_research

If you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com

Posted in CFS Research, CFS in the media, CFSAC, Canadian Criteria, Child protection, Consultations, ME Research, ME events, ME in children, ME in journals, ME in the media, ME in videos, MSBP (FII), XAND, XMRV, XMRV Retrovirus | Comments Off

XMRV Retrovirus: Round up 21: CFSAC videocasts, Testing, Media, CDC Chatter Blog

Posted by meagenda on November 3, 2009

XMRV Retrovirus   Whittemore Peterson   Institute Science   Mikovits   Peterson   Chronic Fatigue Syndrome

XMRV Retrovirus: Round up 21: CFSAC videocasts, Testing, Media and CDC Chatter Blog

WordPress Shortlink: http://wp.me/p5foE-2iU

Videocasts of CFSAC meeting 29-30 October 2008

Around 12 hours of video of the two day CFSAC meeting is now available at:

http://videocast.nih.gov/PastEvents.asp

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 1
Thursday, October 29, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 06:43:49

———-

http://videocast.nih.gov/PastEvents.asp

Chronic Fatigue Syndrome Advisory Committee Meeting (CFSAC) – Day 2
Friday, October 30, 2009
HHS Office on Women’s Health (OWH)
Total Running Time: 05:15:09

Presentation

Dr David Bell’s PowerPoint slides: http://www.hhs.gov/advcomcfs/meetings/agendas/bell_factitious_102909.ppt

Public Testimony
Thursday, October 29, 2009

List of those given testimony plus some PDFs

Friday, October 30, 2009

List of those given testimony plus some PDFs

Written Testimony Received Prior to the Meeting Date

26 PDFs

—————

YouTubes of CFSAC meeting

Clips of Dr Dan Peterson’s presentation and Annette Whittemore: http://www.youtube.com/user/Khalyal

Also on this channel plus some patient testimonies: http://www.youtube.com/user/luminescentfeeling

Dr Dan Peterson presentation in 11 parts here: http://www.youtube.com/user/luminescentfeeling#p/u/11/80yKflt0tcA

—————

Media

Reno Gazette Journal  | 3 November 2009

http://www.rgj.com/article/20091103/NEWS/911030349/1321/news

Hundreds request test for retrovirus
BY LENITA POWERS • lpowers@rgj.com

Overwhelmed by requests from people seeking to have their blood tested for a new retrovirus discovered by researchers at the Whittemore-Peterson Institute for Neuro-Immune Disease in Reno, the institute has arranged for a local laboratory to do the testing.

The flood of requests for blood tests began after the Whittemore-Peterson Institute published a research study in the Oct. 8 online journal Science that showed the prevalence of the retrovirus XMRV in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Viral Immune Pathology Diagnostics (VIP Dx), a small state-certified laboratory in Reno, temporarily will provide testing for the retrovirus XMRV for physicians who request it for their patients at a cost ranging from $400 to $650.

Institute officials said the hope to enter an agreement with a larger laboratory that could handle the demand nationwide, Annette Whittemore, the institute’s founder and president, said Monday…

Read full article here

———————

ProHealth  |  3 November 2009

http://www.prohealth.com/library/showarticle.cfm?libid=14982

Dr. Bell’s November Newsletter – Lyndonville Research Group ‘Back in Business’ with Presentations Planned

Issued in the wee hours of November 3, 2009, Dr. David Bell’s latest free Lyndonville News e-newsletter (http://www.davidsbell.com/index.htm#Latest  announces that the revived Lyndonville ME/CFS Research Group has already initiated four projects, the first being a presentation Dr. Bell will give Sunday, Dec 6 in Batavia, New York “Between Rochester and Buffalo,” fee $10 to cover costs…

Read full article here

——————

University of Florida  College of Medicine  |  3 November 2009

http://news.medinfo.ufl.edu/articles/miscellaneous/event/chronic-fatigue-syndrome-cancer-linked-to-new-virus/

By Czerne Reid

A newly identified virus has been found to be linked to chronic fatigue syndrome and might also provide clues about how to prevent prostate cancer, according to a report this month in the journal Science. Called XMRV, the virus is transmitted in blood and body fluids and might be a significant public health threat.

Judy Mikovits, Ph.D., senior author of the paper, described the research during grand rounds at the University of Florida College of Medicine Thursday, Oct. 20. She was a guest of the division of hematology/oncology…

Read full article here

——————

Reuters Hemispherx Press Release

http://www.reuters.com/article/pressRelease/idUS124102+02-Nov-2009+GNW20091102

Hemispherx Biopharma Updates Chronic Fatigue Syndrome (CFS) Treatment and Commercial…

Mon Nov 2, 2009 8:46am EST

Hemispherx Biopharma Updates Chronic Fatigue Syndrome (CFS) Treatment and Commercial Application Programs

PHILADELPHIA, Nov. 2, 2009 (GLOBE NEWSWIRE) — Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the “Company”), announced a two-prong CFS clinical mission for November and December 2009.

The Company plans to widen its ongoing clinical programs in CFS by accelerating collaborations with a consortium of researchers who have just discovered a retroviral link to Chronic Fatigue Syndrome (please see October 8, 2009, online issue of Science). A clinically validated test to detect retrovirus antibodies in patients plasma is also currently under development (please see US National Institutes of Health at:
http://www.cancer.gov/newscenter/pressreleases/CFSxmrv ).

With the consortium of researchers at the Whittemore Peterson Institute, the Company is also now evaluating the defect in immunosurveillance in specific subsets of CFS patients in a clinical study entitled “Therapeutic Activation of NK lymphocytes to Alleviate Chronic Fatigue Syndrome.” These immune defects may be due to the previously undetected retrovirus…

Read full Press Release here

—————-

About.com  Fibromyalgia  and CFS Blog  | November 3, 2009

http://chronicfatigue.about.com/b/2009/11/03/chronic-fatigue-syndrome-dr-lerner-on-ampligen-xmrv.htm

Chronic Fatigue Syndrome: Dr. Lerner on Ampligen, XMRV

By Adrienne Dellwo, About.com Guide to Fibromyalgia & CFS

Dr. A Martin Lerner: Thoughts on XMRV (Updated), Ampligen

In my recent conversation with Dr. A. Martin Lerner, a former chronic fatigue syndrome sufferer who says he used his specialty in infectious diseases to find treatments for himself and others, I asked him about both the XMRV discovery (which was just days old at the time) and also about Ampligen, the proposed chronic fatigue syndrome drug currently awaiting FDA approval…

Read full article here

—————

Commentary

From Hillary Johnson, author of “Osler’s Web”:

Website: http://oslersweb.com/

Blog: http://oslersweb.com/blog.htm

2 October 2009 via Co-Cure

“I’ve posted a new blog, “CDC MYOCARDIAL INFARCTION,” which reveals agency staff anxiety over the likelihood of reprisals against the CDC for Bill Reeves’ two-decades con job.

http://www.oslersweb.com/blog.htm?post=643435

“The material comes from an internal CDC web site where anonymous posters chat about what worries them. Over the weekend, several people have sent me comments captured from this site before it was shut down on October 29th.”*

Stephen Ralph, of MEActionUK, also presents a comprehensive link to this site, at: http://www.meactionuk.org.uk/CDC_Chatter_Blog_-_Updated_021109.htm

Ed: Note: The site has not been shut down but access to this particular thread is no longer set for public access.

—————-

For initial Whittemore Peterson Press Release, NIH (National Institutes of Health) News Release, Science paper go here: http://wp.me/p5foE-272

Click here for all previous XMRV Round ups and postings in reverse date order: http://meagenda.wordpress.com/category/xmrv/

The Definition Petition

Petition webpage: http://CFSdefinitionpetition.notlong.com
i.e. http://www.ipetitions.com/petition/empirical_defn_and_CFS_research

If you haven’t already signed it – sign the CFS Definition Petition today at: http://CFSdefinitionpetition.notlong.com

Posted in CFS Research, CFS in the media, CFSAC, Canadian Criteria, Child protection, ME Research, ME events, ME in children, ME in journals, ME in the media, ME in videos, MSBP (FII), XAND, XMRV, XMRV Retrovirus | Comments Off